Suppr超能文献

体素S因子对三维内剂量学计算的影响。

Influence of voxel S factors on three-dimensional internal dosimetry calculations.

作者信息

Berenato Salvatore, Amato Ernesto, Fischer Alexander, Baldari Sergio

机构信息

Biomedical Research Group, School of Engineering, Cardiff University, Cardiff, UK.

Section of Radiological Sciences, Department of Biomedical and Dental Sciences and Morpho-functional Imaging, University of Messina, Italy.

出版信息

Phys Med. 2016 Oct;32(10):1259-1262. doi: 10.1016/j.ejmp.2016.09.012. Epub 2016 Sep 19.

Abstract

Internal dosimetry is a fundamental instrument for the personalization of nuclear medicine therapies, to maximize the therapeutic effect while minimizing the radiation burden to other organs. Three-dimensional (3D) dosimetry can quantify the impact of heterogeneous radiopharmaceutical distributions in organs, lesions and tissues. We analysed the influence of radionuclide voxel S factors in 3D dosimetry of In, Lu and Y, the most used radionuclides in Peptide Receptor Radionuclide Therapy (PRRT). Calculations were carried out for kidneys on a workstation equipped with a software for 3D dosimetry (Imalytics STRATOS, Philips AG), adopting a computational anthropomorphic phantom and, retrospectively, the SPECT-CT image series of a clinical case of PRRT. Two sets of voxel S factors were adopted: the pre-loaded Philips kernels, calculated by direct Monte Carlo simulation, and the ones calculated through a previously proposed analytical approach. Philips In kernel did not account for mono-energetic Auger or Conversion electrons. Results indicate a difference of about -32% in voxel S factors for In in 4.42mm voxel size and around -35% in 4.80mm voxel size, particularly self-dose values; this lead to significant shift in dose histograms and average doses. For Lu and Y, differences are about 2% and 12% for 4.42mm voxels and about -8% and 9% for 4.80mm voxels, respectively, attributable to the different calculation methods of the voxel S factors; this does not lead to significant discrepancies between the two dose histograms. Consequently, voxel S factors must account accurately for all radiations emitted by the nuclide.

摘要

体内剂量测定是核医学治疗个体化的一项基本手段,旨在在使对其他器官的辐射负担最小化的同时最大化治疗效果。三维(3D)剂量测定可以量化放射性药物在器官、病变和组织中的非均匀分布的影响。我们分析了放射性核素体素S因子在肽受体放射性核素治疗(PRRT)中最常用的放射性核素铟(In)、镥(Lu)和钇(Y)的3D剂量测定中的影响。在配备有3D剂量测定软件(Imalytics STRATOS,飞利浦公司)的工作站上,采用计算人体模型,并回顾性地使用PRRT临床病例的SPECT-CT图像系列,对肾脏进行了计算。采用了两组体素S因子:预加载的飞利浦内核,通过直接蒙特卡罗模拟计算得出;以及通过先前提出的分析方法计算得出的体素S因子。飞利浦铟内核未考虑单能俄歇电子或内转换电子。结果表明,对于4.42mm体素大小的铟,体素S因子的差异约为-32%,对于4.80mm体素大小的铟,差异约为-35%,特别是自身剂量值;这导致剂量直方图和平均剂量有显著偏移。对于镥和钇,4.42mm体素的差异分别约为2%和12%,4.80mm体素的差异分别约为-8%和9%,这归因于体素S因子的不同计算方法;这并未导致两个剂量直方图之间出现显著差异。因此,体素S因子必须准确考虑核素发射的所有辐射。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验